Discover 1,482 paid clinical trials in Greeley, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,482
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
for
MTAP-deleted Solid Tumors
Location: Denver CO, Irving TX, San Antonio TX, Milwaukee WI,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06914128
Phase 1, Phase 2, Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Denver CO, Nashville TN, Fairfax VA, Trumbull CT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase 1, Recruiting
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
for
Solid Tumors, Adult
Location: Denver CO, Cleveland OH, Plantation FL
Sponsor: Hutchmed
Sex: All
Age: 18+
Code: NCT07228247
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
for
Adult Spinal Deformity, Scoliosis, Kyphosis
Location: Denver CO, Phoenix AZ, Shreveport LA, La Jolla CA,
Sponsor: International Spine Study Group Foundation
Sex: All
Age: 18+
Code: NCT04888104
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Location: Denver CO, Salt Lake City UT, Dallas TX, Little Rock AR,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 19+
Code: NCT06586957
Phase 1, Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Denver CO, Tucson AZ, Cleveland OH, Washington D.C. DC,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase 1, Recruiting
A Study of PYX-201 in Advanced Solid Tumors
for
Solid Tumor, Advanced Solid Tumor
Location: Denver CO, Scottsdale AZ, Dallas TX, St Louis MO,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT05720117
Phase 1, Recruiting
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
for
Intra-amniotic Infection
Location: Denver CO, Mesa AZ, Phoenix AZ, Tucson AZ, St. Louis MO,
Sponsor: ProteoGenix, Inc.
Sex: Female
Age: 18+
Code: NCT00700219
Recruiting
Study of APVO436 in Patients With AML or MDS
for
AML, MDS
Location: Denver CO, Salt Lake City UT, Westwood KS, Dallas TX,
Sponsor: Aptevo Research and Development LLC
Sex: All
Age: 18+
Code: NCT03647800
Phase 1, Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Denver CO, Los Angeles CA, Houston TX, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT03947385
Phase 1, Phase 2, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Denver CO, Omaha NE, Oklahoma City OK, Kansas City KS,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Denver CO, Westwood KS, St Louis MO, Madison WI,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase 1, Recruiting
Interstitial Lung Disease in Early Rheumatoid Arthritis
for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: Denver CO
Sponsor: National Jewish Health
Sex: All
Age: 18 - 70+
Code: NCT03977415
Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Denver CO, Duarte CA, Stanford CA, San Francisco CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
for
Multiple Myeloma
Location: Denver CO, Orange CA, Los Angeles CA, Houston TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05828511
Phase 1, Phase 2, Recruiting
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression